The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|19|1|90-97

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.19, Iss.1, 2013-01, pp. : 90-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content